Technical Analysis for OLMA - Olema Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 26.64 1.91% 0.50
OLMA closed up 1.91 percent on Wednesday, June 23, 2021, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical OLMA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 1.91%
NR7 Range Contraction 1.91%
Older End-of-Day Signals for OLMA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 15 hours ago
60 Minute Opening Range Breakdown about 18 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 2% about 19 hours ago
Up 1% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Hormones Targeted Therapy Epidermal Growth Factor Receptor Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders Fulvestrant

Is OLMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 60.27
52 Week Low 19.41
Average Volume 227,090
200-Day Moving Average 0.00
50-Day Moving Average 27.78
20-Day Moving Average 27.79
10-Day Moving Average 27.85
Average True Range 2.02
ADX 17.91
+DI 21.15
-DI 20.13
Chandelier Exit (Long, 3 ATRs) 26.70
Chandelier Exit (Short, 3 ATRs) 30.25
Upper Bollinger Bands 30.82
Lower Bollinger Band 24.76
Percent B (%b) 0.31
BandWidth 21.80
MACD Line -0.23
MACD Signal Line 0.01
MACD Histogram -0.2364
Fundamentals Value
Market Cap 1.07 Billion
Num Shares 40.2 Million
EPS
Price-to-Sales 0.00
Price-to-Book 15.95
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.01
Resistance 3 (R3) 27.94 27.42 27.78
Resistance 2 (R2) 27.42 27.07 27.45 27.71
Resistance 1 (R1) 27.03 26.85 27.22 27.10 27.63
Pivot Point 26.50 26.50 26.60 26.54 26.50
Support 1 (S1) 26.12 26.16 26.31 26.18 25.65
Support 2 (S2) 25.59 25.94 25.63 25.57
Support 3 (S3) 25.20 25.59 25.50
Support 4 (S4) 25.27